Filter Results:
(1,017)
Show Results For
- All HBS Web
(1,017)
- People (3)
- News (265)
- Research (632)
- Events (1)
- Multimedia (6)
- Faculty Publications (298)
Show Results For
- All HBS Web
(1,017)
- People (3)
- News (265)
- Research (632)
- Events (1)
- Multimedia (6)
- Faculty Publications (298)
- 2024
- Working Paper
HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a diverse cast of characters, including public health organizations, research laboratories, for-profit healthcare companies, activists, and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised May 2024.)
- 1984
- Book
The Results and Interpretation of Three Field Trials of Lysine Fortification of Cereals
By: James E. Austin, Jean Pierre Habicht, Max Milner, Vernon Young and Linda D. Myers
Austin, James E., Jean Pierre Habicht, Max Milner, Vernon Young, and Linda D. Myers. The Results and Interpretation of Three Field Trials of Lysine Fortification of Cereals. Washington, D.C.: National Academy Press, 1984.
- Article
Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials
By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of... View Details
Keywords: Connected Digital Products; Telehealth; Remote Monitoring; Health Testing and Trials; Research; Governing Rules, Regulations, and Reforms; Information Technology
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).
- 13 Dec 2019
- Blog Post
All Is Well in Texas: How Julia Cheek Founded Her At-Home Lab Testing Startup, EverlyWell
was finally ready to start EverlyWell a few years later, her education at HBS allowed her to jumpstart the company. Everlywell is a health and wellness company that provides at-home lab View Details
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- Article
Financial Incentive Based Approaches for Weight Loss: A Randomized Trial
By: Kevin Volpp, Leslie K. John, Andrea Troxel, Laurie Norton, Jennifer Fassbender and George Loewenstein
Volpp, Kevin, Leslie K. John, Andrea Troxel, Laurie Norton, Jennifer Fassbender, and George Loewenstein. "Financial Incentive Based Approaches for Weight Loss: A Randomized Trial." JAMA, the Journal of the American Medical Association 300, no. 22 (December 10, 2008): 2631–2637.
- 17 May 2012
- News
OSHA's Safety Tests Protect Workers at Little Cost: Study
- April 1, 2020
- Article
Coronavirus Is Putting Corporate Social Responsibility to the Test
By: Mark R. Kramer
A great many large companies talk about their values, or about how much they care for their employees and other stakeholders. The coronavirus crisis is the time for them to make good on that commitment. The author offers some things that corporations can do to help... View Details
Kramer, Mark R. "Coronavirus Is Putting Corporate Social Responsibility to the Test." Harvard Business Review Digital Articles (April 1, 2020).
- January 2007
- Article
A Randomized Clinical Trial of EMDR, Fluoxetine and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance
By: Bessel A. van der Kolk, Joseph Spinazzola, Margaret E. Blaustein, James Hopper, Elizabeth Hopper, Deborah Korn and William B. Simpson
van der Kolk, Bessel A., Joseph Spinazzola, Margaret E. Blaustein, James Hopper, Elizabeth Hopper, Deborah Korn, and William B. Simpson. "A Randomized Clinical Trial of EMDR, Fluoxetine and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance." Journal of Clinical Psychiatry 68, no. 1 (January 2007).
- Article
Integrating: A Managerial Practice that Enables Implementation in Fragmented Health Care Environments
By: Michaela J. Kerrissey, Patricia Satterstrom, Nicholas Leydon, Gordon Schiff and Sara J. Singer
How some organizations improve while others remain stagnant is a key question in health care research. This inductive qualitative study examines primary care clinics implementing improvement efforts in order to identify mechanisms that enable implementation despite... View Details
Keywords: Organization And Management Theory; Quality Improvement; Health Care and Treatment; Performance Improvement; Integration; Cooperation
Kerrissey, Michaela J., Patricia Satterstrom, Nicholas Leydon, Gordon Schiff, and Sara J. Singer. "Integrating: A Managerial Practice that Enables Implementation in Fragmented Health Care Environments." Health Care Management Review 42, no. 3 (July–September 2017): 213–225.
- June 2011
- Article
Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial
By: Leslie K. John, George Loewenstein, Andrea Troxel, Laurie Norton, Jennifer Fassbender and Kevin Volpp
John, Leslie K., George Loewenstein, Andrea Troxel, Laurie Norton, Jennifer Fassbender, and Kevin Volpp. "Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial." Journal of General Internal Medicine 26, no. 6 (June 2011): 621–626.
- Web
HBS Health Care Initiative - Blog: Health Supplement
Michael Schrader Author Alumni tag Biotech/pharma Clinical Trials Health Care Entrepreneurship Health Care Innovation Health Care at HBS As an... View Details
- 2021
- Working Paper
The Health Costs of Cost-Sharing
By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost-Sharing." NBER Working Paper Series, No. 28439, February 2021.
- October 2015
- Case
DPDHL Group: Employee Safety and Wellbeing
By: John A. Quelch and Carin-Isabel Knoop
Management at Deutsche Post DHL Group is designing a three-country test of investment in a new health and wellbeing strategy. View Details
Keywords: Health; Wellbeing; Wellness; Safety; Risk; Employees; Human Resources; Risk Management; Service Industry; China; Mexico; Middle East
Quelch, John A., and Carin-Isabel Knoop. "DPDHL Group: Employee Safety and Wellbeing." Harvard Business School Case 516-049, October 2015.
- October 6, 2020
- Article
Test Your Board's Readiness for the Post-COVID Era
By: Lynn S. Paine
Research suggests that well-run boards take the process of self-evaluation quite seriously, often using a combination of director surveys and personal interviews to assess the functioning and effectiveness of the board, its committees, and its individual members. As... View Details
Paine, Lynn S. "Test Your Board's Readiness for the Post-COVID Era." Harvard Business Review Digital Articles (October 6, 2020).
- 18 Oct 2016
- Op-Ed
Why Business Should Invest in Community Health
just beginning their community health push. The capacity of any one non-profit organization to absorb large sums is limited. Because companies also often lack strong relationships with community health... View Details
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- 15 Jan 2021
- News
Two ways Fitbit could boost Google’s health ambitions
- March 30, 2020
- Article
Why Is the U.S. Behind on Coronavirus Testing?
By: Stefan Thomke
Coronavirus testing is needed to address the uncertainty in making decisions about patient treatment, resource allocation, policy, and so much more. Answers to questions such as “When should we relax social distancing measures—and for whom?” or “How many ventilators... View Details
Keywords: Testing; Coronavirus; Culture; Trump; Data; Experiments; Health Pandemics; Health Testing and Trials; Government and Politics; United States
Thomke, Stefan. "Why Is the U.S. Behind on Coronavirus Testing?" Harvard Business Review Digital Articles (March 30, 2020).